Charlotte Ørskov

Learn More
INTRODUCTION Patients with uncomplicated type 2 diabetes are usually managed in general practice. The aim of this study was to describe the duration of contact for patients referred from primary care to a diabetes outpatient clinic. MATERIAL AND METHODS The present study is a retrospective study with follow-up of at least 12 months or until discharged.(More)
BACKGROUND Glucagon-like peptide 2 (GLP-2) is an intestinotrophic mediator with therapeutic potential in conditions with compromised intestinal capacity. However, growth stimulation of the intestinal system may accelerate the growth of existing neoplasms in the intestine. AIMS In the present study, the effects of GLP-2 treatment on the growth of(More)
BACKGROUND The incidence of type 2 diabetes is reaching pandemic proportions, impacting patients and healthcare systems across the globe. Evidence suggests that a majority of patients are not achieving recommended blood glucose targets resulting in an increased risk of micro- and macro-vascular complications. AIM To review literature on the significance(More)
Background: Glucagon-like peptide 2 (GLP-2) is an intestinotrophic mediator with therapeutic potential in conditions with compromised intestinal capacity. However, growth stimulation of the intestinal system may accelerate the growth of existing neoplasms in the intestine. Aims: In the present study, the effects of GLP-2 treatment on the growth of(More)
  • 1